Article Details
Retrieved on: 2018-04-22 14:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>In February 2017 Arix Bioscience successfully listed on the London <b>Stock</b> Exchange, raising £112m. Through Q4 of 2017, significant progress was made in delivering a follow-on raise, which closed in March 2018 having generated a further £87m of funding. These two achievements compare well with ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here